St. Louis, MO. September 15, 2017- Acera is starting a clinical trial on Restrata™ Wound Matrix with a focus on diabetic foot ulcer. Acera will be working with Telos Partner to manage the clinical trial. The study is titled: “Clinical Outcomes after Treatment with Restrata™ in Diabetic Foot Ulcers (DFU): A Case Series of Initial Effectiveness and Safety Measures.”
Please click here to read more from Telos Partners’ press release.